| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/04/2002 | WO2001062257A3 Bupropion metabolites and methods of their synthesis and use |
| 07/04/2002 | WO2001046176A3 Non peptide tachykinin receptor antagonists |
| 07/04/2002 | WO2001041535A9 Eplerenone crystalline form |
| 07/04/2002 | WO2001032183A3 Pharmaceutical compositions comprising oxcarbazepine |
| 07/04/2002 | WO2000069900A9 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 07/04/2002 | US20020086972 Adaptor protein FRS2 and related products and methods |
| 07/04/2002 | US20020086906 Drugs, cosmetics or dietary supplements; immunomodulation, antiallergens (IgE mediated allergies, e.g., asthma, rhinitis, eczema); anaphylaxis; autoimmune disorders, e.g., Crohn's disease, antiarthritic and ulcer agents; analgesics |
| 07/04/2002 | US20020086881 As well as 5-HT3 antagonists and 5-HT4 agonists; for preventing or managing gastro-esophageal reflux disease and/or emesis |
| 07/04/2002 | US20020086880 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| 07/04/2002 | US20020086879 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 07/04/2002 | US20020086871 Pharmaceutical composition for the treatment of CNS and other disorders |
| 07/04/2002 | US20020086865 Use of growth hormone secretagogues for stimulating or increasing appetite |
| 07/04/2002 | US20020086864 Administering optically pure (S,S) enantiomer of reboxetine |
| 07/04/2002 | US20020086859 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 07/04/2002 | US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC |
| 07/04/2002 | US20020086438 Method of preparing delta-9-tetrahydrocannabinol |
| 07/04/2002 | US20020086381 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/04/2002 | US20020086039 As preservative |
| 07/04/2002 | US20020086031 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen |
| 07/04/2002 | US20020086029 For use in inhibiting gastric acid secretion; therapy of gastric acid related diseases |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020086018 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3, and TACI |
| 07/04/2002 | US20020085995 In vivo induction for enhanced function of isolated hepatocytes |
| 07/04/2002 | DE10064994A1 Sulfamidothienopyrimidine Sulfamidothienopyrimidine |
| 07/04/2002 | DE10063435A1 Chinazolinderviate,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Chinazolinderviate, medicaments containing these compounds, their use and process for their preparation |
| 07/04/2002 | DE10063294A1 New N-(heterocyclyl-alkyl)-fused norbornylamine derivatives, are NHE3 inhibitors useful e.g. for treating respiratory disorders, renal failure, intestinal dysfunction, lipid metabolism disorders or proliferative diseases |
| 07/04/2002 | DE10059144A1 Modulation der Transkription pro-inflammatorischer Genprodukte Modulating the transcription of pro-inflammatory gene products |
| 07/04/2002 | CA2441896A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | CA2437209A1 Remedies for hepatitis c |
| 07/04/2002 | CA2436739A1 Combination agent |
| 07/04/2002 | CA2433266A1 Compositions for oral use |
| 07/04/2002 | CA2433090A1 Dipeptidyl peptidase iv inhibitor |
| 07/04/2002 | CA2432715A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | CA2432654A1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2002 | CA2432543A1 Combination drugs |
| 07/04/2002 | CA2432008A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 07/04/2002 | CA2431916A1 New therapeutic uses of smr1 peptides |
| 07/04/2002 | CA2431913A1 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | CA2431883A1 Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof |
| 07/04/2002 | CA2429709A1 Motilide compounds |
| 07/03/2002 | EP1219711A2 Lawsonia intracellularis vaccine |
| 07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
| 07/03/2002 | EP1219630A1 Immunopotentiating compositions |
| 07/03/2002 | EP1219622A2 Pharmaceutical compositions for CNS and other disorders |
| 07/03/2002 | EP1219619A1 Piperidine derivatives |
| 07/03/2002 | EP1219609A1 Aromatic nitrogenous six-membered ring compounds |
| 07/03/2002 | EP1219608A1 Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as the active ingredient |
| 07/03/2002 | EP1218544A1 Methods for identifying rna binding compounds |
| 07/03/2002 | EP1218515A2 Regulation with binding cassette transporter protein abc1 |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218502A2 Nicotinic acetylcholine receptor : alpha10 subunit |
| 07/03/2002 | EP1218498A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 07/03/2002 | EP1218491A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
| 07/03/2002 | EP1218408A1 32 human secreted proteins |
| 07/03/2002 | EP1218401A1 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use |
| 07/03/2002 | EP1218397A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 07/03/2002 | EP1218393A1 Cell targeting compositions and methods of using the same |
| 07/03/2002 | EP1218381A2 AMINO SUBSTITUTED PYRAZOLO 1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO 1,5-a]-1,3,5-TRIAZINES |
| 07/03/2002 | EP1218375A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 07/03/2002 | EP1218374A1 Pharmaceutically active sulfonamide derivatives |
| 07/03/2002 | EP1218373A2 2-pyrazolin-5-ones as tyrosine kinase inhibitors |
| 07/03/2002 | EP1218372A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/03/2002 | EP1218371A2 Di-substituted iminoheterocyclic compounds |
| 07/03/2002 | EP1218369A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/03/2002 | EP1218361A1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 07/03/2002 | EP1218359A2 Piperazine compounds |
| 07/03/2002 | EP1218358A1 Therapeutic quinazoline compounds |
| 07/03/2002 | EP1218347A1 Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions |
| 07/03/2002 | EP1218333A1 Anti-inflammatory nitro- and thia- fatty acids |
| 07/03/2002 | EP1218014A2 Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions |
| 07/03/2002 | EP1218013A2 Phospholipid prodrugs of anti-proliferative drugs |
| 07/03/2002 | EP1218010A2 1,4-benzothiazepines to treat obesity related disorders |
| 07/03/2002 | EP1218007A1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 07/03/2002 | EP1218000A1 Anti-cancer nitro- and thia-fatty acids |
| 07/03/2002 | EP1217975A1 Using quaternary ammonium salts for transdermal drug delivery |
| 07/03/2002 | EP1217902A1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions |
| 07/03/2002 | EP1077912B1 Novel derivatives of 3,3-diphenylpropylamines |
| 07/03/2002 | EP0966466B1 PYRROLO 3,2-c]QUINOLINE DERIVATIVES CONTAINING HALOALKOXY GROUP AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF |
| 07/03/2002 | EP0682521B1 treatment of periodontal disease with misoprostol |
| 07/03/2002 | EP0563345B1 Novel 4-arylpiperazines and 4-arylpiperidines |
| 07/03/2002 | CN1357038A Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions |
| 07/03/2002 | CN1357003A 类固醇衍生物 Steroid derivatives |
| 07/03/2002 | CN1356991A Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
| 07/03/2002 | CN1356990A Bicyclic heterocycles, medicaments contg. these compounds, their use and methods for prodn. thereof |
| 07/03/2002 | CN1356986A Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical prepns. comprising them |
| 07/03/2002 | CN1356911A Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit |
| 07/03/2002 | CN1356902A IL-8 receptor antagonists |
| 07/03/2002 | CN1356899A IL-8 receptor antagonists |
| 07/03/2002 | CN1356893A New formulation |
| 07/03/2002 | CN1356142A Therapeutic vaccine for hepatitis B and its preparing process |
| 07/03/2002 | CN1356134A Capsule 'Dankang' for treating cholecystitis |
| 07/03/2002 | CN1356129A Chinese medicine for comprehensively conditioning functions of human body and its preparing process |
| 07/03/2002 | CN1356124A Medicine for treating hepatism |
| 07/03/2002 | CN1356120A Instant particles 'Daozhihuachong' and its preparing process |
| 07/03/2002 | CN1356114A Chinese patent medicine 'Tongweirunchang' |
| 07/03/2002 | CN1356107A Freezing-dried injection powder 'Katisu' and its preparing process |
| 07/03/2002 | CN1086954C Medicine for treating heavy hepatosis |
| 07/03/2002 | CN1086949C Chinese medicine for hepatitis B and its prepn. |
| 07/02/2002 | US6414157 Compounds having high affinity for 5-ht1b and 5-ht1c serotonin receptor; antidepressants |